Literature DB >> 28989703

An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes.

H V Jain1, J F Boehler2,3, D Verthelyi4, K Nagaraju2,5, S L Beaucage1.   

Abstract

An efficient method for the delivery of uncharged polyA-tailed phosphorodiamidate morpholino sequences (PMO) in mammalian cells consists of employing a synthetic 8-mer amphipathic trans-acting poly-2'-O-methyluridylic thiophosphate triester element (2'-OMeUtaPS) as a transfection reagent. Unlike the dTtaPS DNA-based element, this RNA element is potent at delivering polyA-tailed PMO sequences to HeLa pLuc 705 cells or to myotube muscle cells. However, much like dTtaPS, the 2'-OMeUtaPS-mediated internalization of PMO sequences occurs through an energy-dependent mechanism; macropinocytosis appears to be the predominant endocytic pathway used for cellular uptake. The transfected PMO sequences induce alternate splicing of either the pre-mRNA encoding luciferase in HeLa pLuc 705 cells or the excision of exon 23 from the pre-mRNA encoding dystrophin in myotube muscle cells of the mdx mouse model of muscular dystrophy with an efficiency comparable to that of commercial cationic lipid reagents but without detrimental cytotoxicity.

Entities:  

Year:  2017        PMID: 28989703      PMCID: PMC5625301          DOI: 10.1039/C7RA04247G

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  16 in total

Review 1.  Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.

Authors:  Shantanu Karkare; Deepak Bhatnagar
Journal:  Appl Microbiol Biotechnol       Date:  2006-05-09       Impact factor: 4.813

2.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

3.  Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines.

Authors:  J E Morgan; J R Beauchamp; C N Pagel; M Peckham; P Ataliotis; P S Jat; M D Noble; K Farmer; T A Partridge
Journal:  Dev Biol       Date:  1994-04       Impact factor: 3.582

Review 4.  Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.

Authors:  Toshifumi Yokota; Emidio Pistilli; William Duddy; Kanneboyina Nagaraju
Journal:  Expert Opin Biol Ther       Date:  2007-06       Impact factor: 4.388

Review 5.  Targeting RNA to treat neuromuscular disease.

Authors:  Francesco Muntoni; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

6.  Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.

Authors:  C J Mann; K Honeyman; A J Cheng; T Ly; F Lloyd; S Fletcher; J E Morgan; T A Partridge; S D Wilton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

Review 7.  A chemical view of oligonucleotides for exon skipping and related drug applications.

Authors:  Peter Järver; Liz O'Donovan; Michael J Gait
Journal:  Nucleic Acid Ther       Date:  2013-10-30       Impact factor: 5.486

8.  Parallel synthesis of cell-penetrating peptide conjugates of PMO toward exon skipping enhancement in Duchenne muscular dystrophy.

Authors:  Liz O'Donovan; Itaru Okamoto; Andrey A Arzumanov; Donna L Williams; Peter Deuss; Michael J Gait
Journal:  Nucleic Acid Ther       Date:  2014-11-20       Impact factor: 5.486

9.  Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice.

Authors:  Yoshitsugu Aoki; Tetsuya Nagata; Toshifumi Yokota; Akinori Nakamura; Matthew J A Wood; Terence Partridge; Shin'ichi Takeda
Journal:  Hum Mol Genet       Date:  2013-07-23       Impact factor: 6.150

10.  Elusive sources of variability of dystrophin rescue by exon skipping.

Authors:  Maria Candida Vila; Margaret Benny Klimek; James S Novak; Sree Rayavarapu; Kitipong Uaesoontrachoon; Jessica F Boehler; Alyson A Fiorillo; Marshall W Hogarth; Aiping Zhang; Conner Shaughnessy; Heather Gordish-Dressman; Umar Burki; Volker Straub; Qi Long Lu; Terence A Partridge; Kristy J Brown; Yetrib Hathout; John van den Anker; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  Skelet Muscle       Date:  2015-12-01       Impact factor: 4.912

View more
  1 in total

1.  Synthesis, Characterization, and Function of an RNA-Based Transfection Reagent.

Authors:  Harsh V Jain; Jessica F Boehler; Kanneboyina Nagaraju; Serge L Beaucage
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2018-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.